Innate Pharma revenue breakdown overview

Innate Pharma revenue for the last year amounted to 68.04 M USD, the most of which — 68.04 M USD — came from its highest performing source at the moment, Research and Development of Pharmaceutical Products, the year earlier bringing 61.73 M USD. The greatest contribution to the revenue figure was made by France — last year it brought Innate Pharma 68.04 M USD, and the year before that — 61.73 M USD.